These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 12588327)
21. What is the best way to use conjugate vaccines? Seale A; Finn A Curr Opin Infect Dis; 2011 Jun; 24(3):219-24. PubMed ID: 21522065 [TBL] [Abstract][Full Text] [Related]
22. Evolution of conjugate vaccines. Mäkelä PH; Käyhty H Expert Rev Vaccines; 2002 Oct; 1(3):399-410. PubMed ID: 12901578 [TBL] [Abstract][Full Text] [Related]
23. Haemophilus influenzae type b vaccines: history, choice and comparisons. Decker MD; Edwards KM Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S113-6. PubMed ID: 9781742 [TBL] [Abstract][Full Text] [Related]
24. Recent developments in bacterial conjugate vaccines. Goldblatt D J Med Microbiol; 1998 Jul; 47(7):563-7. PubMed ID: 9839559 [TBL] [Abstract][Full Text] [Related]
25. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP; Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296 [TBL] [Abstract][Full Text] [Related]
26. Comparative effects of carrier proteins on vaccine-induced immune response. Knuf M; Kowalzik F; Kieninger D Vaccine; 2011 Jul; 29(31):4881-90. PubMed ID: 21549783 [TBL] [Abstract][Full Text] [Related]
27. Bacterial polysaccharides as vaccines--immunity and chemical characterization. Lee CJ; Lee LH; Lu CS; Wu A Adv Exp Med Biol; 2001; 491():453-71. PubMed ID: 14533815 [TBL] [Abstract][Full Text] [Related]
28. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines. Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727 [TBL] [Abstract][Full Text] [Related]
29. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta. Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217 [TBL] [Abstract][Full Text] [Related]
30. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388 [TBL] [Abstract][Full Text] [Related]
31. A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. Twumasi PA; Kumah S; Leach A; O'Dempsey TJ; Ceesay SJ; Todd J; Broome CV; Carlone GM; Pais LB; Holder PK J Infect Dis; 1995 Mar; 171(3):632-8. PubMed ID: 7876610 [TBL] [Abstract][Full Text] [Related]
32. Sustaining immunity after immunization against encapsulated bacteria. Blanchard-Rohner G; Pollard AJ Hum Vaccin; 2008; 4(4):309-12. PubMed ID: 18398302 [TBL] [Abstract][Full Text] [Related]
33. A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children. Obaro SK; Huo Z; Banya WA; Henderson DC; Monteil MA; Leach A; Greenwood BM Pediatr Infect Dis J; 1997 Dec; 16(12):1135-40. PubMed ID: 9427458 [TBL] [Abstract][Full Text] [Related]
34. Glycoconjugate vaccines and immune interference: A review. Dagan R; Poolman J; Siegrist CA Vaccine; 2010 Aug; 28(34):5513-23. PubMed ID: 20600514 [TBL] [Abstract][Full Text] [Related]
35. Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger. Campagne G; Garba A; Fabre P; Schuchat A; Ryall R; Boulanger D; Bybel M; Carlone G; Briantais P; Ivanoff B; Xerri B; Chippaux JP Pediatr Infect Dis J; 2000 Feb; 19(2):144-50. PubMed ID: 10694002 [TBL] [Abstract][Full Text] [Related]
36. Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States. Marshall GS; Marchant CD; Blatter M; Friedland LR; Aris E; Miller JM Hum Vaccin; 2011 Feb; 7(2):258-64. PubMed ID: 21307655 [TBL] [Abstract][Full Text] [Related]
37. Prospects for pneumococcal vaccination in African children. Obaro SK Acta Trop; 2000 Mar; 75(2):141-53. PubMed ID: 10708654 [TBL] [Abstract][Full Text] [Related]
38. Structure activity studies on group C meningococcal polysaccharide-protein conjugate vaccines: effect of O-acetylation on the nature of the protective epitope. Michon F; Huang CH; Farley EK; Hronowski L; Di J; Fusco PC Dev Biol (Basel); 2000; 103():151-60. PubMed ID: 11214233 [TBL] [Abstract][Full Text] [Related]
39. Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study. Carmona Martinez A; Prymula R; Miranda Valdivieso M; Otero Reigada MDC; Merino Arribas JM; Brzostek J; Szenborn L; Ruzkova R; Horn MR; Jackowska T; Centeno-Malfaz F; Traskine M; Dobbelaere K; Borys D Vaccine; 2019 Jan; 37(1):176-186. PubMed ID: 30054160 [TBL] [Abstract][Full Text] [Related]
40. Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens. Kelly DF; Pollard AJ; Moxon ER JAMA; 2005 Dec; 294(23):3019-23. PubMed ID: 16414950 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]